ROBERT C MERTON
CIK 1201888 · last filed 2025-06-16
ROBERT C MERTON is a corporate insider who has filed 17 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ASIC, was dated Jun 16, 2025. Across all open-market trades the lifetime net is +$971.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $977.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$977.4K
2
17
$971.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASIC | Director | 47,058 | $20.77 | $977.4K | $800.0K | 1 | 2025-06-16 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Director | 95,451 | — | — | $171.0K | 16 | 2018-05-24 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | ASIC | Mixed | +47,058 | $800.0K | EDGAR |
| 2018-05-24 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-14 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Buy (P) | +85,700 | $150.0K | EDGAR |
| 2017-05-30 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-22 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −4,000 | -$9.0K | EDGAR |
| 2016-12-20 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −4,327 | -$9.6K | EDGAR |
| 2016-06-14 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Buy (P) | +9,000 | $39.1K | EDGAR |
| 2016-05-24 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-26 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | +7,500 | $75 | EDGAR |
| 2013-05-28 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +5,953 | $60 | EDGAR |